NHS buying expensive cancer drugs is causing ‘more harm than good’

The NHS Cancer Drugs Fund has done more harm than good by paying too much for new drugs, health economists have warned. Researchers at the Centre for Health Economics at York University say NHS patients are losing out because the money could be better spent elsewhere, such as filling staff shortages or buying new radiotherapy machines.

Daily Mail